Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02834975
Title Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.